-+ 0.00%
-+ 0.00%
-+ 0.00%

MetaVia To Present Update Highlighting Its Pipeline Of Obesity And Metabolic Therapies At Emerging Growth Conference

Benzinga·02/17/2026 14:07:33
Listen to the news

MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon Kim, President and Chief Executive Officer and Marshall H. Woodworth, Chief Financial Officer, will present a update highlighting the company's pipeline of novel obesity and metabolic therapies at the Emerging Growth Conference on Wednesday, February 25, 2026 at 10:15 am ET.